KERATOSOME™ is an advanced regenerative solution developed and formulated by Genkord, containing 5 billion keratinocyte-derived exosomes suspended in 2-5 ml of physiological saline.

​

Mechanism of Action

KERATOSOME™ uses cellular signals to repair the outermost layer of skin tissue and its structural integrity:

​

Cellular Activation : By stimulating the release of cytokines and growth factors, it activates keratinocytes and fibroblasts, the skin's main repairers; thereby restoring tissue structure and function.

​

Structural Renewal: It initiates the skin's restructuring process by triggering collagen production, extracellular matrix (ECM) synthesis, and new blood vessel formation (angiogenesis).

​

Epithelialization: It accelerates the epithelialization process (formation of the skin covering), which is particularly effective in rapidly closing damaged skin surfaces.

​

Application Method

Offering high tissue repair potential in cases such as burn treatment, skin rejuvenation, scar and acne scar removal, KERATOSOME™ can be applied by a specialist physician according to the needs of the case using surface coating (topical), intradermal (intradermal), or local injection methods.